Colleen Delaney
Chief Tech/Sci/R&D Officer at COEPTIS THERAPEUTICS HOLDINGS, INC.
Net worth: - $ as of 2024-04-29
Profile
Colleen Delaney is the founder of Nohla Therapeutics, Inc., Deverra Therapeutics, Inc. She currently holds multiple positions.
She is a Director at the American Society for Blood & Marrow Transplantation.
She is also a Director at Vicapsys Life Sciences, Inc. starting in 2022.
In addition, she is the Chief Scientific & Medical Officer at Coeptis Therapeutics Holdings, Inc. starting in 2023.
Dr. Delaney is also a Clinical Professor at the University of Washington.
Previously, she worked as a Professor at the Fred Hutchinson Cancer Research Center and the Fred Hutchinson Cancer Center.
Dr. Delaney received a graduate degree from the University of Oxford and a doctorate degree from Harvard Medical School in 1996.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-21 | 0 ( -.--% ) | - $ | 2024-04-29 |
Colleen Delaney active positions
| Companies | Position | Start |
|---|---|---|
| VICAPSYS LIFE SCIENCES, INC. | Director/Board Member | 2022-09-21 |
| COEPTIS THERAPEUTICS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 2023-08-29 |
| American Society for Blood & Marrow Transplantation | Director/Board Member | - |
Deverra Therapeutics, Inc.
 Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Founder | - |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Former positions of Colleen Delaney
| Companies | Position | End |
|---|---|---|
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Fred Hutchinson Cancer Center
 Fred Hutchinson Cancer Center Hospital/Nursing ManagementHealth Services Fred Hutchinson Cancer Center is a research and patient care institution that is committed to eradicating cancer and related diseases as causes of human suffering and death. The center conducts research and provides patient care of the highest standards to improve the prevention and treatment of cancer and related diseases. | Corporate Officer/Principal | - |
Nohla Therapeutics, Inc.
 Nohla Therapeutics, Inc. BiotechnologyHealth Technology Nohla Therapeutics, Inc. developed cellular therapies for hematological disorders. The firm's products used without the need for HLA matching and promote hematopoietic recovery in patients at risk for neutropenia after intensive chemotherapy and/or radiation treatment for critical diseases. The company was founded by Colleen Delaney and was headquartered in Seattle, WA. | Founder | - |
Training of Colleen Delaney
| University of Oxford | Graduate Degree |
| Harvard Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| VICAPSYS LIFE SCIENCES, INC. | Health Technology |
| COEPTIS THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Commercial Services |
| American Society for Blood & Marrow Transplantation | |
Nohla Therapeutics, Inc.
Nohla Therapeutics, Inc. BiotechnologyHealth Technology Nohla Therapeutics, Inc. developed cellular therapies for hematological disorders. The firm's products used without the need for HLA matching and promote hematopoietic recovery in patients at risk for neutropenia after intensive chemotherapy and/or radiation treatment for critical diseases. The company was founded by Colleen Delaney and was headquartered in Seattle, WA. | Health Technology |
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Health Technology |
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center Hospital/Nursing ManagementHealth Services Fred Hutchinson Cancer Center is a research and patient care institution that is committed to eradicating cancer and related diseases as causes of human suffering and death. The center conducts research and provides patient care of the highest standards to improve the prevention and treatment of cancer and related diseases. | Health Services |
- Stock Market
- Insiders
- Colleen Delaney